Magnetite-Amyloid-β deteriorates activity and functional organization in an in vitro model for Alzheimer's disease

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Teller, Sara ^a   Tahirbegi, Islam Bogachan ^a,b   Mir, Mònica ^b,c   Samitier, Josep ^a,b,c   Soriano, Jordi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTE FOR BIOENGINEERING OF CATALONIA IBEC   (Spain)

^c BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; MAGNETITE;

ALZHEIMER DISEASE; ANIMAL; BIOLOGICAL MODEL; CELL AGGREGATION; CELL CULTURE; DRUG EFFECTS; NERVE CELL; PATHOLOGY; SPRAGUE DAWLEY RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CELL AGGREGATION; CELLS, CULTURED; FERROSOFERRIC OXIDE; MODELS, BIOLOGICAL; NEURONS; RATS, SPRAGUE-DAWLEY;

EID: 84948166188     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17261     Document Type: Article

References (61)

1. Hardy, J. A. & Higgins, G. A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185 (1992).
2. Hardy, J. & Selkoe, D. J. The Amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356 (2002).
3. Tsai, J., Grutzendler, J., Duff, K. & Gan, W.-B. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci 7, 1181-1183 (2004).
4. Goodman, L. Alzheimer's disease: a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. J Nerv Ment Dis 118, 97-130 (1953).
5. Ke, Y. & Qian, Z. M. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2, 246-253 (2003).
6. Castellani, R. J., Moreira, P. I., Perry, G. & Zhu, X. The role of iron as a mediator of oxidative stress in Alzheimer disease. Biofactors 38, 133-138 (2012).
7. Mucke, L. Neuroscience: Alzheimer's disease. Nature 461, 895-897 (2009).
8. Lannfelt, L. et al. Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer's disease. Alzheimers Res Ther 6, article 16 (2014).
9. Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T. & Lansbury, P. T. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291-291 (2002).
10. Demuro, A. et al. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280, 17294-17300 (2005).
11. Kawahara, M., Ohtsuka, I., Yokoyama, S., Kato-Negishi, M. & Sadakane, Y. Membrane incorporation, channel formation, and disruption of calcium homeostasis by alzheimer's β-amyloid protein. Int J Alzheimers Dis 2011, 304583 (2011).
12. Demuro, A., Parker, I. & Stutzmann, G. E. Calcium signaling and amyloid toxicity in Alzheimer disease. J Biol Chem 285, 12463-12468 (2010).
13. Smith, M. A., Harris, P. L., Sayre, L. M. & Perry, G. Iron accumulation in alzheimer disease is a source of redox-generated free radicals. P Natl Acad Sci USA 94, 9866-9868 (1997).
14. Everett, J. et al. Evidence of redox-active iron formation following aggregation of ferrihydrite and the Alzheimer's disease peptide β-amyloid. Inorg Chem 53, 2803-2809 (2014).
15. Hautot, D., Pankhurst, Q., Khan, N. & Dobson, J. Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue. P Roy Soc B - Biol Sci 270, S62-S64 (2003).
16. Collingwood, J. et al. In situ characterization and mapping of iron compounds in Alzheimer's disease tissue. J Alzheimers Dis 7, 267-272 (2005).
17. Pankhurst, Q., Hautot, D., Khan, N. & Dobson, J. Increased levels of magnetic iron compounds in Alzheimer's disease. J Alzheimers Dis 13, 49-52 (2008).
18. Mir, M., Tahirbegi, I. B., Valle-Delgado, J. J., Fernàndez-Busquets, X. & Samitier, J. In vitro study of magnetite-amyloid β complex formation. Nanomed-Nanotechnol 8, 974-980 (2012).
19. Hartley, D. M. et al. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19, 8876-8884 (1999).
20. Dahlgren, K. N. et al. Oligomeric and fibrillar species of Amyloid-β peptides differentially affect neuronal viability. J Biol Chem 277, 32046-32053 (2002).
21. O'Nuallain, B. et al. Amyloid β-protein dimers rapidly form stable synaptotoxic protofibrils. J Neurosci 30, 14411-14419 (2010).
22. Gabay, T., Jakobs, E., Ben-Jacob, E. & Hanein, Y. Engineered self-organization of neural networks using carbon nanotube clusters. Physica A 350, 611-621 (2005).
23. Sorkin, R. et al. Compact self-wiring in cultured neural networks. J Neural Eng 3, 95-101 (2006).
24. Tsai, C.-Y., Chang, M.-C. & I., L. Robustness and variability of pathways in the spontaneous synchronous bursting of clusterized cortical neuronal networks in vitro. J Phys Soc Jpn 77, 084803 (2008).
25. Teller, S. et al. Emergence of assortative mixing between clusters of cultured neurons. PLoS Comput Biol 10, e1003796 (2014).
26. Shein-Idelson, M., Ben-Jacob, E. & Hanein, Y. Modular topology introduces gating in neuronal networks through excitation-inhibition balance. In MEA Meeting 2012, 33-36.
27. Newman, M. Assortative mixing in networks. Phys Rev Lett 89, 208701 (2002).
28. Geddes, J. W., Anderson, K. J. & Cotman, C. W. Senile plaques as aberrant sprout-stimulating structures. Exp Neurol 94, 767-776 (1986).
29. Huang, Y. & Mucke, L. Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204-1222 (2012).
30. Musiek, E. S. & Holtzman, D. M. Three dimensions of the amyloid hypothesis: time, space and 'wingmen'. Nat Neurosci 18, 800-806 (2015).
31. Karran, E., Mercken, M. & De Strooper, B. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10, 698-712 (2011).
32. Mucke, L. et al. High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20, 4050-4058 (2000).
33. Mattson, M. P. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci 21, 53-57 (1998).
34. Chen, Y., McPhie, D. L., Hirschberg, J. & Neve, R. L. The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons. J Biol Chem 275, 8929-8935 (2000).
35. Arispe, N., Pollard, H. B. & Rojas, E. Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. P Natl Acad Sci USA 90, 10573-10577 (1993).
36. Hensley, K. et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. P Natl Acad Sci USA 91, 3270-3274 (1994).
37. Reitz, C. Alzheimer's disease and the amyloid cascade hypothesis: A critical review. Int J Alzheimers Dis 2012, 369808 (2012).
38. Cummings, B. J., Pike, C. J., Shankle, R. & Cotman, C. W. Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol Aging 17, 921-933 (1996).
39. Beauchemin, D. & Kisilevsky, R. A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques. Anal Chem 70, 1026-1029 (1998).
40. Beard, J. L., Connor, J. R. & Jones, B. C. Iron in the brain. Nutr Rev 51, 157-170 (1993).
41. Loo, D. T. et al. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. P Natl Acad Sci USA 90, 7951-7955 (1993).
42. Delbeuck, X., Van der Linden, M., Collette, F. & Linden, M. V. D. Alzheimer's disease as a disconnection syndrome? Neuropsychol Rev 13, 79-92 (2003).
43. Wang, J. et al. Disrupted functional brain connectome in individuals at risk for Alzheimer's disease. Biol Psychiat 73, 472-481 (2013).
44. Buldú, J. M. et al. Reorganization of functional networks in mild cognitive impairment. PLoS One 6, e19584 (2011).
45. Shu, N. et al. Disrupted topological organization in white matter structural networks in amnestic mild cognitive impairment: relationship to subtype. Radiology 265, 518-527 (2012).
46. Bai, L. et al. Characterizing acupuncture De Qi in mild cognitive impairment: relations with small-world efficiency of functional brain networks. Evid-Based Compl Alt 2013, 304804 (2013).
47. Pascual-Leone, A. et al. Characterizing brain cortical plasticity and network dynamics across the age-span in health and disease with tms-eeg and tms-fmri. Brain Topogr 24, 302-315 (2011).
48. Dickerson, B. C. et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 65, 404-411 (2005).
49. Borge-Holthoefer, J., Moreno, Y., Arenas, A. & Perc, M. Modeling abnormal priming in Alzheimer's patients with a free association network. PLoS One 6, e22651 (2011).
50. Orlandi, J. G., Soriano, J., Alvarez-Lacalle, E., Teller, S. & Casademunt, J. Noise focusing and the emergence of coherent activity in neuronal cultures. Nat Phys 9, 582-590 (2013).
51. Sato, N. et al. Development of new screening system for Alzheimer disease, in vitro Abeta sink assay, to identify the dissociation of soluble Abeta from fibrils. Neurobiol Dis 22, 487-495 (2006).
52. Dahlgren, K. N. et al. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277, 32046-32053 (2002).
53. Bishop, G. M. & Robinson, S. R. Human Aβ1-42 reduces iron-induced toxicity in rat cerebral cortex. J Neurosci Res 73, 316-323 (2003).
54. Kuo, Y.-M. et al. Water-soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem 271, 4077-4081 (1996).
55. Reichardt, J. & Bornholdt, S. Statistical mechanics of community detection. Phys Rev E 74, 016110 (2006).
56. Kaufman, L. & Rousseeuw, P. J. Finding groups in data: an introduction to cluster analysis (John Wiley & Sons, 2009).
57. Karrer, B., Levina, E. & Newman, M. E. J. Robustness of community structure in networks. Phys Rev E 77, 1-9 (2008).
58. Meilə, M. Comparing clusterings - an information based distance. J Multivariate Anal 98, 873-895 (2007).
59. Rubinov, M. & Sporns, O. Complex network measures of brain connectivity: uses and interpretations. Neuroimage 52, 1059-1069 (2010).
60. Gómez, S. 'Radatools: communities detection in complex networks and other tools' (2011). Available at http://deim.urv.cat/sergio.gomez/radatools.php. Date of access: 17/04/2015.
61. Tibau, E., Valencia, M. & Soriano, J. Identification of neuronal network properties from the spectral analysis of calcium imaging signals in neuronal cultures. Front Neural Circuits 7, article 199 (2013).